Paper23745006
Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema.
Nunes S and 3 others. Invest Ophthalmol Vis Sci, 2013. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema. Papers, record 23745006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23745006
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Retinopathy | Major topic |
| Macular Edema | Major topic |
| Aged | |
| Cluster Analysis | |
| Diabetes Mellitus, Type 2 | |
| Disease Progression | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Phenotype | |
| Prospective Studies | |
| Risk Factors | |
| Tomography, Optical Coherence | |
| Visual Acuity |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00763802 | Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2 | Derived from the trial | Yes |
Source ClinicalTrials.gov
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41693808 | The Association of Lapses in Diabetic Retinopathy Care with Vision Impairment. | Ophthalmol Sci | 2026 | https://conductscience.org/library/papers/41693808 | PubMed |
| 40646245 | Understanding nonproliferative diabetic retinopathy progression using noninvasive imaging. | Eye (Lond) | 2025 | https://conductscience.org/library/papers/40646245 | PubMed |
| 39061684 | Distribution of Microaneurysms and Hemorrhages in Accordance with the Grading of Diabetic Retinopathy in Type Diabetes Patients. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/39061684 | PubMed |
| 38667478 | Referable Diabetic Retinopathy Prediction Algorithm Applied to a Population of 120,389 Type 2 Diabetics over 11 Years Follow-Up. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/38667478 | PubMed |
| 36494431 | Perspectives of diabetic retinopathy-challenges and opportunities. | Eye (Lond) | 2023 | https://conductscience.org/library/papers/36494431 | PubMed |
| 36185322 | Recent developments on computer aided systems for diagnosis of diabetic retinopathy: a review. | Multimed Tools Appl | 2023 | https://conductscience.org/library/papers/36185322 | PubMed |
| 35757010 | Retinal Neurodegeneration in Different Risk Phenotypes of Diabetic Retinal Disease. | Front Neurosci | 2021 | https://conductscience.org/library/papers/35757010 | PubMed |
| 35158351 | Association between Neurodegeneration and Macular Perfusion in the Progression of Diabetic Retinopathy: A 3-Year Longitudinal Study. | Ophthalmologica | 2022 | https://conductscience.org/library/papers/35158351 | PubMed |
| 34865186 | Characterization of One-Year Progression of Risk Phenotypes of Diabetic Retinopathy. | Ophthalmol Ther | 2022 | https://conductscience.org/library/papers/34865186 | PubMed |
| 34070479 | Optical Coherence Tomography Angiography Metrics Monitor Severity Progression of Diabetic Retinopathy-3-Year Longitudinal Study. | J Clin Med | 2021 | https://conductscience.org/library/papers/34070479 | PubMed |
| 33706717 | Population segmentation of type 2 diabetes mellitus patients and its clinical applications - a scoping review. | BMC Med Res Methodol | 2021 | https://conductscience.org/library/papers/33706717 | PubMed |
| 33025221 | Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression. | Acta Diabetol | 2021 | https://conductscience.org/library/papers/33025221 | PubMed |
| 32408522 | Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy. | J Clin Med | 2020 | https://conductscience.org/library/papers/32408522 | PubMed |
| 32181799 | Characterization of Disease Progression in the Initial Stages of Retinopathy in Type 2 Diabetes: A 2-Year Longitudinal Study. | Invest Ophthalmol Vis Sci | 2020 | https://conductscience.org/library/papers/32181799 | PubMed |
| 31388757 | [Unmet research and developmental needs in ophthalmology : A consensus-based road map of the European Vision Institute for 2019-2025]. | Ophthalmologe | 2019 | https://conductscience.org/library/papers/31388757 | PubMed |
| 31160916 | Plasma metabolomic profiling of proliferative diabetic retinopathy. | Nutr Metab (Lond) | 2019 | https://conductscience.org/library/papers/31160916 | PubMed |
| 30581604 | Applications of Artificial Intelligence in Ophthalmology: General Overview. | J Ophthalmol | 2018 | https://conductscience.org/library/papers/30581604 | PubMed |
| 29699981 | Microaneurysm turnover is a predictor of diabetic retinopathy progression. | Br J Ophthalmol | 2019 | https://conductscience.org/library/papers/29699981 | PubMed |
| 28729371 | Geographic atrophy phenotype identification by cluster analysis. | Br J Ophthalmol | 2018 | https://conductscience.org/library/papers/28729371 | PubMed |
| 27306616 | Extravascular modified lipoproteins: a role in the propagation of diabetic retinopathy in a mouse model of type 1 diabetes. | Diabetologia | 2016 | https://conductscience.org/library/papers/27306616 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23745006
GET https://conductscience.org/api/papers/v1/23745006/cited_by?page=2